TSE:CRON Cronos Group (CRON) Stock Price, News & Analysis → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free CRON Stock Alerts C$3.55 -0.11 (-3.01%) (As of 03/28/2024 ET) Add Compare Share Share Today's RangeC$3.55▼C$3.7550-Day RangeC$2.62▼C$3.6652-Week RangeC$2.15▼C$3.75Volume452,820 shsAverage Volume183,572 shsMarket CapitalizationC$1.35 billionP/E RatioN/ADividend YieldN/APrice TargetC$2.77 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlines Get Cronos Group alerts: Email Address Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> About Cronos Group Stock (TSE:CRON)Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Read More CRON Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRON Stock News HeadlinesMarch 25, 2024 | finance.yahoo.comCronos Group Inc. Ontario Securities Class Action NoticeMarch 22, 2024 | americanbankingnews.comCronos Group (TSE:CRON) Shares Up 1.9%March 29, 2024 | Vertical Research Advisory (Ad)“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!March 18, 2024 | msn.com1 High-Yield Dividend King to Scoop Up While It's CheapMarch 16, 2024 | finance.yahoo.comCRON Oct 2024 2.500 putMarch 15, 2024 | benzinga.comSmart Money Is Betting Big In Altria Group OptionsMarch 1, 2024 | finance.yahoo.comCronos Group Inc. (NASDAQ:CRON) Q4 2023 Earnings Call TranscriptFebruary 20, 2024 | msn.comLaw enforcement agencies disrupt prolific ransomware group LockBitMarch 29, 2024 | Vertical Research Advisory (Ad)“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!February 19, 2024 | msn.comLockbit cybercrime gang disrupted by international police operationFebruary 19, 2024 | msn.comLockBit ransomware gang disrupted by global operationFebruary 15, 2024 | msn.comThe highs and lows of yeast-derived cannabisFebruary 15, 2024 | msn.comEni drills second well at Cronos gas discovery off CyprusFebruary 15, 2024 | msn.com‘Excellent’ Cronos gas discovery off CyprusFebruary 14, 2024 | finance.yahoo.comCronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024February 13, 2024 | morningstar.comCronos Group Inc CRONFebruary 5, 2024 | investing.comCronos Group Inc (CRON)February 3, 2024 | finance.yahoo.comWhile public companies own 41% of Cronos Group Inc. (TSE:CRON), retail investors are its largest shareholders with 44% ownershipFebruary 1, 2024 | finance.yahoo.comMurray R. Garnick, Executive Vice President & General Counsel, Announces Decision to RetireJanuary 25, 2024 | finance.yahoo.comCronos’ Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1January 9, 2024 | msn.comCanadian Cannabis Co. Cronos Explores Untapped Potential In Australia's Marijuana IndustryJanuary 9, 2024 | finance.yahoo.comCronos Enters Australian Cannabis MarketDecember 28, 2023 | markets.businessinsider.comCronos Group Sell Rating Affirmed Amid Modest Sales Forecasts and Competitive ChallengesDecember 28, 2023 | markets.businessinsider.comB of A Securities Maintains Underperform Rating for Cronos Group: Here's What You Need To KnowDecember 18, 2023 | finance.yahoo.com12 Best CBD Stocks To Buy NowDecember 15, 2023 | finance.yahoo.comPremium Cannabis Brand Lord Jones® Launches Live Resin VapesNovember 27, 2023 | msn.comCronos Group (CRON) Price Target Increased by 5.54% to 2.61See More Headlines Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/29/2024Next Earnings (Estimated)5/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:CRON CUSIPN/A CIKN/A Webwww.thecronosgroup.com Phone416-504-0004FaxN/AEmployees447Year FoundedN/APrice Target and Rating Average Stock Price TargetC$2.77 High Stock Price TargetC$2.82 Low Stock Price TargetC$2.72 Potential Upside/Downside-22.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth0.12Net IncomeC$-69,850,000.00 Net Margins-84.78% Pretax MarginN/A Return on Equity-6.30% Return on Assets-4.24% Debt Debt-to-Equity Ratio0.23 Current Ratio22.54 Quick Ratio24.01 Sales & Book Value Annual SalesC$87.24 million Price / Sales15.52 Cash FlowC$2.12 per share Price / Cash Flow1.67 Book ValueC$2.88 per share Price / Book1.23Miscellaneous Outstanding Shares381,300,000Free FloatN/AMarket CapC$1.35 billion OptionableNot Optionable Beta1.04 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Michael Ryan Gorenstein J.D. (Age 37)President, CEO & Chairman Comp: $5.3MMr. James Holm (Age 41)Chief Financial Officer Comp: $422.9kMr. Jeffrey David Jacobson (Age 38)Chief Growth Officer Comp: $982.37kMs. Anna Shlimak (Age 38)Senior Vice President of Corporate Affairs & Strategy Comp: $713.79kMr. James Andrew McGinness III (Age 45)VP, Controller & Principal Accounting Officer Mr. Shayne J. LaidlawDirector of Investor Relations & StrategyMr. Terry Gregory-Joseph Doucet (Age 34)General Counsel & Corporate Secretary Ms. Shannon Buggy (Age 54)Senior VP & Global Head of People Comp: $590.42kMr. Arye Weigensberg (Age 41)Senior VP & Head of Research and Development More ExecutivesKey CompetitorsHydropothecaryCVE:THCXCanopy GrowthTSE:WEEDKnight TherapeuticsTSE:GUDTilray BrandsTSE:TLRYBausch Health CompaniesTSE:BHCView All Competitors CRON Stock Analysis - Frequently Asked Questions Should I buy or sell Cronos Group stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CRON shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares. View CRON analyst ratings or view top-rated stocks. What is Cronos Group's stock price target for 2024? 2 brokerages have issued 12 month price objectives for Cronos Group's shares. Their CRON share price targets range from C$2.72 to C$2.82. On average, they anticipate the company's stock price to reach C$2.77 in the next year. This suggests that the stock has a possible downside of 22.0%. View analysts price targets for CRON or view top-rated stocks among Wall Street analysts. How have CRON shares performed in 2024? Cronos Group's stock was trading at C$2.77 at the beginning of the year. Since then, CRON stock has increased by 28.2% and is now trading at C$3.55. View the best growth stocks for 2024 here. When is Cronos Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our CRON earnings forecast. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), Walt Disney (DIS) and Intel (INTC). How do I buy shares of Cronos Group? Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:CRON) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.